InvestorPlace Earnings

InvestorPlace Earnings

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

Recent Articles

AVTX Stock Earnings: Avalo Therapeutics Misses EPS for Q2 2024

By InvestorPlace Earnings

AVTX stock results show that Avalo Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.

ADAP Stock Earnings: Adaptimmune Therapeutics Beats EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

ADAP stock results show that Adaptimmune Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

LPTX Stock Earnings: Leap Therapeutics Misses EPS for Q2 2024

By InvestorPlace Earnings

LPTX stock results show that Leap Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.

BTDR Stock Earnings: Bitdeer Technologies Beats EPS, Misses Revenue for Q2 2024

By InvestorPlace Earnings

BTDR stock results show that Bitdeer Technologies beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

TCRX Stock Earnings: TScan Therapeutics Meets EPS, Misses Revenue for Q2 2024

By InvestorPlace Earnings

TCRX stock results show that TScan Therapeutics met analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

Load More